Protocol of a drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV.

Ashley Lacombe-Duncan Alice Tseng Kimberly K Scarsi Tessa SennekerHadas KlugerYasmeen PersadAngela UnderhillV Logan KennedyIan ArmstrongRaymond FungAmy BournsQuang NguyenSusan HranilovicThea WeisdorfLouie ChanHannah KiaRoberta HalpennyHarshita IyerNirubini JeyarajahGeorge KovchazovWangari TharaoMona Loutfy

Published in: British journal of clinical pharmacology (2024)

This study is of global importance as it provides critical information regarding safe coadministration of B/F/TAF and FHT, both of which are life-saving therapies for trans women with HIV.

Keyphrases

antiretroviral therapy
randomized controlled trial
hepatitis c virus
human immunodeficiency virus
hiv infected
emergency department
healthcare
hiv aids
hiv positive
south africa
adipose tissue
hiv testing
drug induced